It is known that polymorphisms at TCF7L2 are strongly associated with risk of diabetes, obesity, and other metabolic disturbances, hinting that our results may be relevant for human disease. This evidence concerns the gene TCF7L2 and obesity due to melanocortin 4 receptor deficiency.